Laura Hogan, MD

Dr. Hogan is an expert in Pediatric Hematology Oncology with a particular focus on acute leukemia, oncology survivorship, and Adolescent and Young Adult (AYA) cancer care.  Her research focuses on clinical trials to improve outcomes in newly diagnosed and relapsed children, adolescents, and young adults with acute lymphoblastic leukemia and on the late effects seen in survivors of pediatric cancer.  As a survivor of childhood leukemia, she is passionate about improving survival rates in children with cancer and reducing their late effects.

The Progression of Bone Mineral Density Abnormalities After Chemotherapy for Childhood Acute Lymphoblastic Leukemia. Vitanza NA, Hogan LE, Zhang G, Parker RI; Journal of pediatric hematology/oncology, 2015 Jul

Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia. Meyer JA, Wang J, Hogan LE, Yang JJ, Dandekar S, Patel JP, Tang Z, Zumbo P, Li S, Zavadil J, Levine RL, Cardozo T, Hunger SP, Raetz EA, Evans WE, Morrison DJ, Mason CE, Carroll WL; Nature genetics, 2013 Mar

Endogenous knockdown of survivin improves chemotherapeutic response in ALL models. Morrison DJ, Hogan LE, Condos G, Bhatla T, Germino N, Moskowitz NP, Lee L, Bhojwani D, Horton TM, Belitskaya-Levy I, Greenberger LM, Horak ID, Grupp SA, Teachey DT, Raetz EA, Carroll WL; Leukemia, 2012 Feb

Treating persistent distress and anxiety in parents of children with cancer: an initial feasibility trial. Warner CM, Ludwig K, Sweeney C, Spillane C, Hogan L, Ryan J, Carroll W; Journal of pediatric oncology nursing: official journal of the Association of Pediatric Oncology Nurses, 2011 Jul-Aug

Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Hogan LE, Meyer JA, Yang J, Wang J, Wong N, Yang W, Condos G, Hunger SP, Raetz E, Saffery R, Relling MV, Bhojwani D, Morrison DJ, Carroll WL; Blood, 2011 Nov 10

Dying to predict outcome. Hogan LE, Raetz EA; Pediatric blood & cancer, 2010 Jul 15